NeRRe Therapeutics' Series B Round

NeRRe Therapeutics raised a round of funding on January 05, 2017.

NeRRe Therapeutics is a private, UK-based clinical-stage company focused on the development of its unique portfolio of NK receptor antagonists for the treatment of common, chronic and debilitating con…

Articles about NeRRe Therapeutics' Series B Round: